Accession Number: | 0001127602-20-016580 |
Date: | 2020-05-12 |
Issuer: | BIOCRYST PHARMACEUTICALS INC (BCRX) |
Original Submission Date: |
LEVIN ALAN G
4505 EMPEROR BLVD.
SUITE 200
DURHAM, NC 27703
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
AUTOMATIC STOCK OPTION GRANT | 5.41 | 2020-05-12 | deemed execution date | A | 40,000 (a) | 2021-05-12 | 2030-05-12 | common stock 40,000 | $5.41 | 40,000 | direct |
ID | footnote |
---|---|
f1 | automatic non-employee director grant pursuant to the biocryst pharmaceuticals, inc. stock incentive plan. |